Xiaohu Deng

Title: Innovations of Xiaohu Deng in Cancer Treatment

Introduction

Xiaohu Deng is a notable inventor based in Cardiff, CA (US), recognized for his contributions to the field of cancer treatment. His innovative work focuses on methods to treat virally associated cancers using histone deacetylase inhibitors (HDACi). With a keen understanding of the complexities involved in cancer therapies, Deng has made significant strides in improving treatment outcomes.

Latest Patents

Deng holds a patent titled "Methods of treating virally associated cancers with histone deacetylase inhibitors." This patent describes specific dosing schedules and amounts that effectively prevent and manage side effects associated with HDACi treatment. Additionally, the patent suggests that these schedules may include treatment with an antiviral agent, enhancing the overall efficacy of the therapy. He has 1 patent to his name.

Career Highlights

Xiaohu Deng is affiliated with Viracta Therapeutics Inc., a company dedicated to advancing innovative therapies for cancer treatment. His role at the company allows him to collaborate with other experts in the field, furthering research and development in oncology.

Collaborations

Deng has worked alongside notable colleagues such as Robert McRae and Gail L Brown. Their combined expertise contributes to the advancement of cancer treatment methodologies and the exploration of new therapeutic avenues.

Conclusion

Xiaohu Deng's innovative approaches in cancer treatment exemplify the potential of targeted therapies in managing virally associated cancers. His contributions through patents and collaborations highlight the importance of continued research in this critical area of medicine.